Parkinsonism, Lrrk2 G2019S, and tau neuropathology

Neurology. 2006 Oct 24;67(8):1506-8. doi: 10.1212/01.wnl.0000240220.33950.0c.

Abstract

Lrrk2 G2019S is predominantly associated with alpha-synuclein-immunopositive Lewy body pathology. We have identified Family SK where Lrrk2 G2019S segregates with slowly progressive parkinsonism and the affected proband has tau-immunopositive neurofibrillary tangle pathology. Thus alpha-synucleinopathy and tauopathy, the predominant pathologies associated with parkinsonism, may be alternate outcomes of the same underlying genetic cause. Intriguingly, we observe no evidence of a direct interaction between either the tau or alpha-synuclein protein with Lrrk2.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Brain / metabolism
  • Brain / pathology
  • Cell Line
  • Disability Evaluation
  • Disease Progression
  • Female
  • Glycine
  • Humans
  • Immunohistochemistry
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Male
  • Middle Aged
  • Mutation*
  • Neurofibrillary Tangles / metabolism*
  • Neurofibrillary Tangles / pathology
  • Parkinsonian Disorders / genetics*
  • Parkinsonian Disorders / pathology*
  • Parkinsonian Disorders / physiopathology
  • Pedigree
  • Protein Serine-Threonine Kinases / genetics*
  • Serine
  • alpha-Synuclein / metabolism
  • tau Proteins / metabolism*

Substances

  • alpha-Synuclein
  • tau Proteins
  • Serine
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases
  • Glycine